Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Women with PCOS often have liver disease, so liver health checks are important for them.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

Women with PCOS have higher oxidative stress and hormone imbalances, suggesting managing oxidative stress could help.

Excess androgens may cause PCOS, not just be a symptom.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

PCOS is a complex condition that can lead to serious health issues, but early diagnosis and treatment can reduce these risks.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

Skin problems in PCOS, like excess hair, acne, and hair loss, may not always indicate high male hormone levels and need careful diagnosis for proper treatment.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Metformin may help regulate periods and cause modest weight loss in PCOS patients, but more research is needed.

Isotretinoin may cause temporary, reversible facial hair growth in some women.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.